MedTrace Logo

Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance

NCT00663000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2014-09-16

No results posted yet for this study

Summary

Observational, Cross-sectional, longitudinal, multi-center, diagnostic study

Cross-sectional part of the study: To evaluate the influence of acromegaly on glucose tolerance

Longitudinal part of the study: To evaluate the changes of impaired glucose tolerance during standard treatment of acromegaly. Adult patients with established acromegaly

Cross-sectional part of the study: 150 patients

Longitudinal part of the study: 58 patients

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Baptist Gallwitz, MD, Prof. · Dept. Medicine IV. Tuebingen University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-04-30
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00663000 on ClinicalTrials.gov